Lipofectamine Mediated Gene Delivery: Cationic Lipid Helps to Overcome the Cell-Surface Barriers in Hepatocytes

Authors

  • Biswanath Patra Daniel Baugh Institute for Functional Genomics/Computational Biology, Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, 1020 Locust street, 320A JAH, Philadelphia (19107), PA

Keywords:

Lipofectamine, hepatocyte, HEK293, PGL3, GFP plasmid, TEX615

Abstract

The objective of this study is to find effective siRNA delivery vehicle targeting liver, specifically into hepatocytes. Recently developed cationic lipid lipofectamine provide a very high density of positive charges along its backbone and have been reported to be effective in siRNA delivery to target liver cells. We compared lipofectamine mediated siRNA delivery with a cationic polymer based approach (jetPEI), in cultured fresh rat hepatocytes and human embryonic kidney cell line HEK293. We tested plasmids encoding either GFP or luciferase, and a TEX615 red dye labeled oligo to examine efficient translocation into primary hepatocytes in culture. Our results clearly dem­onstrated the higher efficacy of lipofectamine over jetPEI in targeting hepatocytes for both plasmid and labeled oligo delivery.

Downloads

Download data is not yet available.

Downloads

Published

2011-09-07

How to Cite

1.
Patra B. Lipofectamine Mediated Gene Delivery: Cationic Lipid Helps to Overcome the Cell-Surface Barriers in Hepatocytes. IJBSM [Internet]. 2011 Sep. 7 [cited 2025 Sep. 21];2(Sep, 3):313-9. Available from: https://ojs.pphouse.org/index.php/IJBSM/article/view/162

Issue

Vol. 2 No. Sep, 3 (2011)

Section

Articles

License

Authors retain copyright. Articles published are made available as open access articles, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited. Creative Commons License

This journal permits and encourages authors to share their submitted versions (preprints), accepted versions (postprints) and/or published versions (publisher versions) freely under the CC BY-NC-SA 4.0 license while providing bibliographic details that credit, if applicable.